Low dose 1/3 - 1/10

Slow action

Frequent-Continuous

Frequent-Continuous

Multi-targets

Multi-targets

Haemangiostasis controls endothelial cell

Antiangiogenesis

Immunological adjustment

Immunological

Maintenance/Prevention

Prevention/Maintenance

Oral

Oral

Side effects low

Side effects low